Bachem has shocked the pharmaceutical industry with its massive $2.3 billion acquisition of AmWiner, marking one of the largest deals in the peptide therapeutics sector this year. This strategic takeover signals Bachem's ambitious plans Wegovy manufacturer to dominate the growing market for peptide-based medications and expand its global footprint